Novel ciprofloxacin and norfloxacin-tetrazole hybrids as potential antibacterial and antiviral agents: Targeting S. aureus topoisomerase and SARS-CoV-2-MPro

Authors:

Abstract
No abstract available
Funding Information
  • Natural Sciences and Engineering Research Council of Canada (RGPIN-2017-06023)
  • Secretaría de Ciencia, Humanidades, Tecnología e Innovación (SEP-82585)

This publication has 74 references indexed in Scilit: